JAMA Dermatology

<jats:p>This case report describes a patient with refractory porokeratosis ptychotropica who experienced substantial improvement in symptoms with upadacitinib treatment.</jats:p>

Treatment of porokeratosis ptychotropica with a topical combination of cholesterol and simvastatin.

JAMA Dermatol

Safety and efficacy of topical simvastatin plus cholesterol cream versus topical simvastatin cream alone for porokeratosis ptychotropica: a randomized, single-blind, split-body, placebo-controlled, investigator-initiated trial.

J Am Acad Dermatol

Genomic variations of the mevalonate pathway in porokeratosis.

Elife

Clonal expansion of second-hit cells with somatic recombinations or C&gt;T transitions form porokeratosis in MVD or MVK mutant heterozygotes.

J Invest Dermatol

The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch.

Cell

Targeted anti-interleukin-17 therapy for linear porokeratosis.

Br J Dermatol

This case report describes a patient with refractory porokeratosis ptychotropica who experienced substantial improvement in symptoms with upadacitinib treatment.

Treatment of Porokeratosis Ptychotropica With Upadacitinib.

Treatment of Porokeratosis Ptychotropica With Upadacitinib

Treatment of Porokeratosis Ptychotropica With Upadacitinib

Clinical Summary

What was studied

Key findings

Study limitations

Related Questions